<DOC>
	<DOC>NCT01030705</DOC>
	<brief_summary>This study will collect data on features for future pacemakers via an external non-implantable system.</brief_summary>
	<brief_title>Common Sensing and Right Ventricular Automatic Capture (COGNATE)</brief_title>
	<detailed_description>COGNATE is an acute, confirmatory prospective, multi-center study designed to gather data on Brady and CRT-P indicated patients, with no restrictions on the type/brand of leads. This study will enroll up to 80 patients in up to 12 centers. Total duration of the study is expected to be 9 months.</detailed_description>
	<mesh_term>Bradycardia</mesh_term>
	<criteria>Patients who are scheduled to receive either Pacemaker (dual chamber) or CRTP devices based on physician discretion Patients who are willing and capable of participating in all testing associated with this Clinical Investigation Patients who are age 18 or above, or of legal age to give informed consent specific to state and national law Patient enrolled in any concurrent study, without Boston Scientific CRM written approval, that may confound the results of this study Patients with a prosthetic mechanical tricuspid heart valve Women who are pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Bradycardia</keyword>
	<keyword>pacemaker</keyword>
</DOC>